Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia. uri icon

authors

  • Graveno, Molly E
  • Hexner, Elizabeth O
  • Luger, Selina M
  • Martin, Mary Ellen
  • Shannon R. McCurdy, MD
  • Perl, Alexander E
  • Babushok, Daria V
  • Pratz, Keith W
  • Carulli, Alison
  • Freyer, Craig W
  • Mangan, Brendan L
  • Nietupski, Robert
  • Loren, Alison W
  • Frey, Noelle V
  • Porter, David L
  • Gill, Saar I

publication date

  • March 8, 2022